Opdivo No Longer FDA-Approved for Small Cell Lung Cancer
In 2018, the FDA granted accelerated approval to Opdivo for SCLC based on data from the phase 1/2 CheckMate -032 trial.
Oncology
Smoking Risks for Colorectal Cancer to Discuss With Patients
Smoking is consistently seen as a risk for various cancers, and in recent years it has been connected to colorectal cancer in particular.
New Mammogram-Based Measures Improve Breast Cancer Prediction
New mammogram-based risk measures based on brightness and texture improve breast cancer risk prediction beyond an established measure of mammographic density.
Kidney Cancer Stage Migrated Downward in Low Income Patients After ACA
Higher proportions of patients in the low to middle income brackets were diagnosed with localized renal cell carcinoma in states allowing Medicaid expansion.
Prior Radiation Linked to Worse Survival in Bladder Cancer Cases
This study examined bladder cancer that developed after radiation for any cancer potentially affecting the organ, not just prostate cancer.
Inappropriate Imaging of Low-Risk Prostate Cancer Patients Continues
Use of computed tomography and bone scans in low-risk prostate cancer cases has been in decline, but doctors continue to order these imaging modalities despite professional guidelines that do not recommend such use.
Top November 2020 FDA Approvals
Several previously FDA-approved medicines were approved for additional uses in November 2020.
Medicaid Expansion Tied to Increased Detection of Early Cancers
Medicaid expansion under the Affordable Care Act was linked to an increase in early-stage cancer diagnoses in the first year after expansion.
Top October 2020 FDA Approvals
The FDA has approved therapies for the treatment of COVID-19, leukemia, Ebola, and pediatric adrenocortical insufficiency in October 2020.
Understanding the Stigma Experienced by Patients With Prostate Cancer
Interview study identifies men’s perception and concerns related to their prostate cancer journey.
-
Loading...
-
Loading...
Next post in Men's Health Information Center
